Inspirational Leadership: Ronald Sokol, MD
Dr. Ronald Sokol’s life work revolves around the research and treatment of childhood liver diseases and other pediatric disorders.
Creating a Safe Environment in Healthcare
This safety-themed edition of BioSupply Trends Quarterly addresses this patient safety and how it can be improved.
Frontrunner Solutions in Genetic Testing Diagnostics: Mark Harris
Mark Harris, PhD, is the founder and chief executive officer of NextGxDx, a healthcare information company that provides a web-based genetic diagnostics marketplace.
Plasma Therapies: From Supply to Dosing and Reimbursement
In this plasma-themed issue of BioSupplyTrends Quarterly, we take a critical look at each of these segments of the plasma market.
A Vision for Global Leadership – Paolo Marcucci
Kedrion President and CEO Paolo Marcucci discusses Kedrion’s goal to strengthen its role as strategic partner of national health systems.
The Human and Economic Value of Healthcare Innovation
In this issue, we explore novel technologies shaping the future of the healthcare landscape.
Immunization: An Era of Innovation
As we celebrate our third year in publication, we begin by exploring innovations in vaccine research and technology.
Leading the Way in Vaccine Innovation: Brent MacGregor
Brent MacGregor, president of Novartis Vaccines, U.S., plans to build upon the current Novartis Vaccines culture, which he says promotes an entrepreneurial spirit coupled with an element of risk-taking that he thrives on.
Meeting the Needs of Patients Globally: Gregory Rich
With a global presence in more than90 countries, Grifols had long established itself as a standard-bearer within the plasma therapies industry.
Danger Ahead: The Growing Safety Challenges
With the number of counterfeit drug investigations having grown almost tenfold in the last five years, the number of prescription drug shortages nearly tripling from 2005 to 2010, and with recent indications that this threat is increasing rather than diminishing, keeping patients safe has never been more challenging.